BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34360546)

  • 1. Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.
    Munkhjargal A; Kim MJ; Kim DY; Jeon YJ; Kee YH; Kim LK; Kim YH
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48.
    Velimezi G; Robinson-Garcia L; Muñoz-Martínez F; Wiegant WW; Ferreira da Silva J; Owusu M; Moder M; Wiedner M; Rosenthal SB; Fisch KM; Moffat J; Menche J; van Attikum H; Jackson SP; Loizou JI
    Nat Commun; 2018 Jun; 9(1):2280. PubMed ID: 29891926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.
    Chun MJ; Kim S; Hwang SK; Kim BS; Kim HG; Choi HI; Kim JH; Goh SH; Lee CH
    Oncotarget; 2016 Aug; 7(33):53642-53653. PubMed ID: 27449087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
    Guervilly JH; Macé-Aimé G; Rosselli F
    Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of FANCD2 Inhibits the FANCD2/FANCI Complex and Suppresses the Fanconi Anemia Pathway in the Absence of DNA Damage.
    Lopez-Martinez D; Kupculak M; Yang D; Yoshikawa Y; Liang CC; Wu R; Gygi SP; Cohn MA
    Cell Rep; 2019 Jun; 27(10):2990-3005.e5. PubMed ID: 31167143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses.
    Peng M; Xie J; Ucher A; Stavnezer J; Cantor SB
    EMBO J; 2014 Aug; 33(15):1698-712. PubMed ID: 24966277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
    Jeong E; Lee SG; Kim HS; Yang J; Shin J; Kim Y; Kim J; Schärer OD; Kim Y; Yeo JE; Kim HM; Cho Y
    Nucleic Acids Res; 2020 Apr; 48(6):3328-3342. PubMed ID: 32002546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for subcomplexes in the Fanconi anemia pathway.
    Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
    Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the FA pathway mediated by phosphorylation and ubiquitination.
    Ishiai M; Sato K; Tomida J; Kitao H; Kurumizaka H; Takata M
    Mutat Res; 2017 Oct; 803-805():89-95. PubMed ID: 28552166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
    Wang X; Kennedy RD; Ray K; Stuckert P; Ellenberger T; D'Andrea AD
    Mol Cell Biol; 2007 Apr; 27(8):3098-108. PubMed ID: 17296736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
    Bick G; Zhang F; Meetei AR; Andreassen PR
    Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UHRF1 is a sensor for DNA interstrand crosslinks and recruits FANCD2 to initiate the Fanconi anemia pathway.
    Liang CC; Zhan B; Yoshikawa Y; Haas W; Gygi SP; Cohn MA
    Cell Rep; 2015 Mar; 10(12):1947-56. PubMed ID: 25801034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of Fanconi anemia mutations in China.
    Li N; Ding L; Li B; Wang J; D'Andrea AD; Chen J
    Exp Hematol; 2018 Oct; 66():32-41.e8. PubMed ID: 30031030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition.
    Palle K; Vaziri C
    Cell Cycle; 2011 May; 10(10):1625-38. PubMed ID: 21478670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination.
    Ishiai M
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.